2nd Quarter - Report

PARRY, ROMANI, DECONCINI & SYMMS for NOVARTIS CORP

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

S. 515/H.R. 1260, Patent Reform Act of 2009. To amend title 35, United States Code, relating to the procurement, enforcement, and validity of patents. Lobbied to protect intellectual property rights. Sought amendments to insure the enforceability of patents.

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —
STEVE SYMMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1260 (111th), S. 515 (111th)

Health Issues HCR

Support legislation to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare, Part B. Support legislation to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. Support legislation to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act to ensure a sufficient supply of vaccines and for other purposes. Lobbied to ensure that the Internet would not be used to import counterfeit and defective medical products. Support a rigorous and workable Affordable Biologics for Consumers Act. Support enactment and follow-on Biologics legislation with amendments that strengthen FDA pathway and provide data exclusivity. General matters related to vaccine industry stability, pandemic preparedness, avian influenza.

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —
STEVE SYMMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. ____, The Labor, HHS Appropriations bill for FY2010, funding for domestic vaccine supply, Centers for Disease Control, National Institutes of Health and Vaccine Injury Compensation Fund. (No bill introduced/number yet.)

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —
STEVE SYMMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Monitor Healthcare Reform. S.____, Affordable Health Choices Act (HELP Committee bill); S. ____, Finance Committee bill not yet introduced; and H.R. _____, America's Affordable Health Choices Act of 2009. (The above bills have not yet been introduced and as such, no bill numbers are available.)

Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.

LobbyistCovered position, as disclosed
EDWARD H BAXTER —
ROMANO ROMANI —
STEVE SYMMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.